NB100-716

antibody from Novus Biologicals

Targeting: CXCR4 CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R

Western blot (Data presented on provider website)

ELISA (Data presented on provider website)

Immunohistochemistry (Supportive data in Antibodypedia)

Antibody Data

Product number

NB100-716

Provider

Novus Biologicals

Proper citation

Novus Cat#NB100-716, RRID:AB_10003456

Product name

Goat Polyclonal CXCR4 Antibody

Antibody type

Polyclonal

Description

Immunogen affinity purified. Peptide sequence is < 50% identical to other human chemokine receptors in this region

Reactivity

Human, Rat

Host

Goat

Isotype

IgG

Vial size

0.1 mg

Concentration

1.0 mg/ml

Storage

Store at -20C. Avoid freeze-thaw cycles.

References

Submitted references

Chemokine receptor CXCR4 activates the RhoA/ROCK2 pathway in spinal neurons that induces bone cancer pain.

Xu H, Peng C, Chen XT, Yao YY, Chen LP, Yin Q, Shen W
Molecular pain 2020 Jan-Dec;16:1744806920919568

---

Chemokine receptor CXCR4 regulates CaMKII/CREB pathway in spinal neurons that underlies cancer-induced bone pain.

Hu XM, Zhang H, Xu H, Zhang HL, Chen LP, Cui WQ, Yang W, Shen W
Scientific reports 2017 Jun 21;7(1):4005

---

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma.

Diomedi-Camassei F, McDowell HP, De Ioris MA, Uccini S, Altavista P, Raschellà G, Vitali R, Mannarino O, De Sio L, Cozzi DA, Donfrancesco A, Inserra A, Callea F, Dominici C
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Jul 1;14(13):4119-27

Immunohistochemistry

Supportive validation

Submitted by

Novus Biologicals (provider)

Main image

Experimental details

Immunohistochemistry-Paraffin: CXCR4 Antibody [NB100-716] - Human spleen